Partner Tom Bulleit (Washington, D.C.) co-authored a May 17 article in Law360 analyzing the Trump administration’s four-point plan for curbing prescription drug prices.
The authors break down the administration’s key proposals and likely paths forward, including assessing whether potential changes could be made quickly by administrative action, or are more likely to take more time and require legislation.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.